Literature DB >> 7682400

Keratin specificity analyses of eight anti-keratin monoclonal antibodies, and their immunostaining patterns in normal skin using formalin-fixed and paraffin-embedded tissue specimens.

S I Ansai1, Y Katagata, K I Yoshikawa, Y Hozumi, K Aso.   

Abstract

Keratin specificity analyses of eight anti-keratin antibodies (34 beta B4 (K1), 35 beta H11 (K8), Ks 13.1 (K13), Ks 19.1 (K19), PKK1, LP34 (CK1), KL1 and AE1) using keratin protein derived from normal thigh epidermis, normal parotid gland and a human squamous cell carcinoma cell line (HSC-5) were performed, and compared with those described in the data sheets. The reactivities of LP34, KL1 and PKK1 were markedly different from those mentioned in the data sheets. The immunostaining pattern of these antibodies in normal skin using formalin-fixed and paraffin-embedded tissue specimens was also examined. The staining patterns of suprabasal keratinocytes (K1, K13, CK1 and KL1 positive), basal cells of the epidermis (PKK1 and AE1 positive), inner cells of the ducts (K8, K13, CK1, KL1 and AE1 positive) and secretory cells of sweat glands (K8, K19, PKK1, KL1 and AE1 positive), mature cells (K8 and KL1 positive) and peripheral cells (CK1, KL1 and AE1 positive) of sebaceous glands and outer root sheaths (PKK1, CK1, KL1 and AE1 positive) were specific. Thus, we conclude that the differentiation of epidermis and skin appendages is possible by immunostaining with these eight anti-keratin antibodies using formalin-fixed and paraffin-embedded tissue specimens with proper protease pretreatment.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7682400     DOI: 10.1007/bf00370816

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  24 in total

1.  Separation of cytokeratin polypeptides by gel electrophoretic and chromatographic techniques and their identification by immunoblotting.

Authors:  T Achtstaetter; M Hatzfeld; R A Quinlan; D C Parmelee; W W Franke
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

2.  Paget cells express cytokeratins typical of glandular epithelia.

Authors:  A L Kariniemi; F Ramaekers; V P Lehto; I Virtanen
Journal:  Br J Dermatol       Date:  1985-02       Impact factor: 9.302

3.  Anti-keratin monoclonal antibody against basal cell epithelioma keratin: BKN-1.

Authors:  N Shimizu; M Ito; T Tazawa; K Katsuumi; Y Sato
Journal:  J Dermatol       Date:  1987-08       Impact factor: 4.005

4.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Expression of EGF receptor, involucrin, and cytokeratins in basal cell carcinomas and squamous cell carcinomas of the skin.

Authors:  A P Lavrijsen; L M Tieben; M Ponec; J G van der Schroeff; G N van Muijen
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

7.  Human squamous cell carcinoma from skin: establishment and characterization of a new cell line (HSC-5).

Authors:  Y Hozumi; S Kondo; T Shimoura; K Aso
Journal:  J Dermatol       Date:  1990-03       Impact factor: 4.005

8.  Comparative cytokeratin analysis of sweat gland ducts and eccrine poromas.

Authors:  I Moll; R Moll
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

9.  Distribution of cytokeratin polypeptides in syringomas. An immunohistochemical study on paraffin-embedded material.

Authors:  F Eckert; M Nilles; U Schmid; M Altmannsberger
Journal:  Am J Dermatopathol       Date:  1992-04       Impact factor: 1.533

10.  Immunohistochemical staining patterns of sweat glands and their neoplasms using two monoclonal antibodies to keratins.

Authors:  J A Zuk; K P West; A Fletcher
Journal:  J Cutan Pathol       Date:  1988-02       Impact factor: 1.587

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.